These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 26992879)

  • 1. Effectiveness of Adherence Therapy for People With Schizophrenia in Turkey: A Controlled Study.
    Dikec G; Kutlu Y
    Arch Psychiatr Nurs; 2016 Apr; 30(2):249-56. PubMed ID: 26992879
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of mindfulness-based psychoeducation on insight and medication adherence of schizophrenia patients.
    Çetin N; Aylaz R
    Arch Psychiatr Nurs; 2018 Oct; 32(5):737-744. PubMed ID: 30201202
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effect of Internalized Stigma on the Adherence to Treatment in Patients With Schizophrenia.
    Yılmaz E; Okanlı A
    Arch Psychiatr Nurs; 2015 Oct; 29(5):297-301. PubMed ID: 26397432
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of insights on medication adherence in patients with schizophrenia.
    Kalkan E; Kavak Budak F
    Perspect Psychiatr Care; 2020 Jan; 56(1):222-228. PubMed ID: 31215655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Are we addressing the 'right stuff' to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication.
    Beck EM; Cavelti M; Kvrgic S; Kleim B; Vauth R
    Schizophr Res; 2011 Oct; 132(1):42-9. PubMed ID: 21820875
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antipsychotic medication adherence and satisfaction among Palestinian people with schizophrenia.
    Sweileh WM; Ihbesheh MS; Jarar IS; Sawalha AF; Abu Taha AS; Zyoud SH; Morisky DE
    Curr Clin Pharmacol; 2012 Feb; 7(1):49-55. PubMed ID: 22299769
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Treatment adherence and insight in schizophrenia.
    Bitter I; Fehér L; Tényi T; Czobor P
    Psychiatr Hung; 2015; 30(1):18-26. PubMed ID: 25867885
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patient adherence and efficacy of quetiapine treatment in schizophrenia: results of a multicentre, naturalistic 6-month follow-up study.
    Alptekin K; Aydin H; Gucer KM; Dilbaz N; Goka E; Esendemir C; Oguz H; Arabul G; Aslaner F; Ayer A; Celiker AR; Cirit H; Pinar Z; Unal A
    Int Clin Psychopharmacol; 2010 Nov; 25(6):342-8. PubMed ID: 20924243
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An exploratory, randomized controlled trial of adherence therapy for people with schizophrenia.
    Anderson KH; Ford S; Robson D; Cassis J; Rodrigues C; Gray R
    Int J Ment Health Nurs; 2010 Oct; 19(5):340-9. PubMed ID: 20887608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of patient and clinician perspectives in the assessment of antipsychotic medication adherence.
    Barbui C; Kikkert M; Mazzi MA; Becker T; Bindman J; Schene A; Nosè M; Helm H; Thornicroft G; Tansella M
    Psychopathology; 2009; 42(5):311-7. PubMed ID: 19672133
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The ability of multifamily groups to improve treatment adherence in Mexican Americans with schizophrenia.
    Kopelowicz A; Zarate R; Wallace CJ; Liberman RP; Lopez SR; Mintz J
    Arch Gen Psychiatry; 2012 Mar; 69(3):265-73. PubMed ID: 22393219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relationships between insight and medication adherence in subjects with psychosis].
    Droulout T; Liraud F; Verdoux H
    Encephale; 2003; 29(5):430-7. PubMed ID: 14615692
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A large-scale validation study of the Medication Adherence Rating Scale (MARS).
    Fialko L; Garety PA; Kuipers E; Dunn G; Bebbington PE; Fowler D; Freeman D
    Schizophr Res; 2008 Mar; 100(1-3):53-9. PubMed ID: 18083007
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug attitude and other predictors of medication adherence in schizophrenia: 12 months of electronic monitoring (MEMS(®)) in the Swedish COAST-study.
    Brain C; Allerby K; Sameby B; Quinlan P; Joas E; Karilampi U; Lindström E; Eberhard J; Burns T; Waern M
    Eur Neuropsychopharmacol; 2013 Dec; 23(12):1754-62. PubMed ID: 24091164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adherence to antipsychotic drug treatment in early-episode schizophrenia: a six-month naturalistic follow-up study.
    Baloush-Kleinman V; Levine SZ; Roe D; Shnitt D; Weizman A; Poyurovsky M
    Schizophr Res; 2011 Aug; 130(1-3):176-81. PubMed ID: 21636254
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Strategies for measuring medication adherence in patients with schizophrenia].
    Wang Y; Huang Z; Xu D; Gong W; Tang Y; Xiao S
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Feb; 41(2):218-24. PubMed ID: 26932222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptom severity and attitudes toward medication: impacts on adherence in outpatients with schizophrenia.
    Yang J; Ko YH; Paik JW; Lee MS; Han C; Joe SH; Jung IK; Jung HG; Kim SH
    Schizophr Res; 2012 Feb; 134(2-3):226-31. PubMed ID: 22133906
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Rationale for the use of long-acting injectable risperidone: a survey of French psychiatrists].
    Misdrahi D; Delgado A; Bouju S; Comet D; Chiariny JF
    Encephale; 2013 May; 39 Suppl 1():S8-14. PubMed ID: 23541914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How do socio-demographic and clinical factors interact with adherence attitude profiles in schizophrenia? A cluster-analytical approach.
    Beck EM; Cavelti M; Wirtz M; Kossowsky J; Vauth R
    Psychiatry Res; 2011 May; 187(1-2):55-61. PubMed ID: 21074860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A peer support programme for enhancing adherence to oral antipsychotic medication in consumers with schizophrenia.
    Boardman G; McCann T; Kerr D
    J Adv Nurs; 2014 Oct; 70(10):2293-302. PubMed ID: 24628395
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.